Antimicrobial Susceptibility Testing Market Analysis
The global Antimicrobial Susceptibility Testing Market, valued at USD 3.57 billion in 2023, is projected to reach USD 5.35 billion by 2031. This significant growth is expected to occur at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031, according to the latest market analysis.
Antimicrobial susceptibility testing (AST) plays a crucial role in guiding the effective use of antibiotics and managing antimicrobial resistance (AMR). The market's steady growth is driven by the rising incidence of infectious diseases, increasing prevalence of AMR, and advancements in diagnostic technologies.
Key Factors Driving Market Growth:
By Product
By Technique
By Application
By End-Use
Future Outlook:
The Antimicrobial Susceptibility Testing Market is poised for steady growth, driven by the rising incidence of infectious diseases, the growing threat of AMR, and advancements in diagnostic technologies. As healthcare providers and public health organizations continue to prioritize effective antibiotic use and resistance management, the adoption of AST is expected to expand, providing significant opportunities for innovation and growth.
Women’s Health Therapeutics Market Size
Tinnitus Management Market Size
Needle-Free Injector Market Size
At present there are zero comments on this article.
Why not be the first to make a comment?
There are zero sub-categories in this parent category.
There are zero sub-categories in this parent category.